A recent meta-analysis published in Frontiers of Oncology is making waves in both the medical and wellness communities. The study—funded by Cancer Playbook and led by Ryan Castle, research director at Whole Health Oncology Institute—reviewed more than 10,000 research articles and found a surprising degree of consensus: medical cannabis has the potential to significantly relieve symptoms associated with cancer.
The comprehensive research, which is being called the largest analysis of its kind, employed an AI-powered tool known as “sentiment analysis” to assess a wide array of studies. The findings revealed that a “significant majority” of the research leaned favorably toward the use of medical cannabis for managing symptoms such as appetite loss, nausea, and inflammation.
“We expected to find a moderate consensus,” Castle told The Guardian. “But the results were closer to three-to-one in favor of medical cannabis being effective. That’s a shocking degree of agreement in public health research, especially in a field historically marked by controversy and conflicting data.”
The analysis is a milestone in the push to establish a scientific consensus around cannabis as a therapeutic option for cancer patients, especially as many studies in the past were cherry-picked to support opposing narratives.
As the conversation around plant-based wellness continues to evolve, this groundbreaking study could pave the way for new medical approaches and policies centered on the use of cannabis as a supportive treatment for cancer.
Stay informed with daily updates on cannabis business news by subscribing to our newsletter.
